Edition:
India

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

6.22USD
19 Jul 2019
Change (% chg)

$-0.21 (-3.27%)
Prev Close
$6.43
Open
$6.42
Day's High
$6.44
Day's Low
$6.19
Volume
133,915
Avg. Vol
319,708
52-wk High
$14.00
52-wk Low
$4.82

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.373
FY 2018 Dec '18 0.00 -0.327
Sep '18 0.00 -0.314
Jun '18 0.00 -0.298
Mar '18 0.00 -0.316
FY 2017 Dec '17 5.21 -0.114
Sep '17 0.00 -0.206
Jun '17 0.00 -0.311
Mar '17 4.79 -0.201
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 9 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 9 0.00 0.00 0.00 0.00
Year Ending Dec-19 9 0.00 0.00 0.00 7.00
Year Ending Dec-20 9 5.56 50.00 0.00 49.75
Earnings (per share)
Quarter Ending Sep-19 10 -0.37 -0.32 -0.45 -0.35
Quarter Ending Dec-19 10 -0.38 -0.31 -0.50 -0.36
Year Ending Dec-19 10 -1.49 -1.36 -1.74 -1.20
Year Ending Dec-20 10 -1.57 -0.91 -2.03 -0.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -38.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cymabay Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 37.82 33.06 99 --
13 Week 45.13 38.06 99 --
26 Week 100.98 85.70 99 --
52 Week 355.56 286.12 99 --
YTD 373.99 316.26 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 195
Total Shares Held: 71,528,701
3 Mo. Net Change: 3,563,569
# New Positions: 8
# Closed Positions: 2
# Increased Positions: 13
# Reduced Positions: 9
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.